Valeo Financial Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,086
Closed -$778K 2088
2021
Q1
$778K Hold
5,086
0.04% 207
2020
Q4
$795K Buy
5,086
+4,316
+561% +$555K 0.04% 181
2020
Q3
$88K Sell
770
-36
-4% -$3.88K 0.01% 502
2020
Q2
$90K Sell
806
-364
-31% -$38.6K 0.01% 536
2020
Q1
$114K Hold
1,170
0.01% 396
2019
Q4
$127K Buy
1,170
+500
+75% +$53.5K 0.01% 409
2019
Q3
$66K Sell
670
-600
-47% -$67.6K 0.01% 526
2019
Q2
$166K Buy
1,270
+595
+88% +$76.7K 0.02% 322
2019
Q1
$91K Buy
675
+198
+42% +$24.6K 0.01% 430
2018
Q4
$46K Sell
477
-208
-30% -$24.6K 0.01% 519
2018
Q3
$77K Sell
685
-108
-14% -$13.5K 0.01% 465
2018
Q2
$94K Sell
793
-285
-26% -$33.3K 0.01% 408
2018
Q1
$120K Hold
1,078
0.02% 331
2017
Q4
$129K Buy
1,078
+33
+3% +$4.02K 0.02% 297
2017
Q3
$147K Buy
+1,045
New +$142K 0.03% 236

Other funds holding ALXN